Urate and neuroprotection trials--authors' reply

Affiliations

¹ Hospital Clinic, 08036 Barcelona, Spain. Electronic address: achamorro@clinic.ub.es.
² Hospital Clinic, 08036 Barcelona, Spain.
³ Institut d'Investigacions Biomèdiques, 08036 Barcelona, Spain.

Comment

Ángel Chamorro et al. Lancet Neurol. 2014 Aug.

. 2014 Aug;13(8):758-9.

doi: 10.1016/S1474-4422(14)70139-5.

¹ Hospital Clinic, 08036 Barcelona, Spain. Electronic address: achamorro@clinic.ub.es.
² Hospital Clinic, 08036 Barcelona, Spain.
³ Institut d'Investigacions Biomèdiques, 08036 Barcelona, Spain.

No abstract available

Comment on

Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM; URICO-ICTUS Investigators. Chamorro A, et al. Lancet Neurol. 2014 May;13(5):453-60. doi: 10.1016/S1474-4422(14)70054-7. Epub 2014 Apr 2. Lancet Neurol. 2014. PMID: 24703208 Clinical Trial.
Urate and neuroprotection trials.
Schwarzschild MA, Macklin EA, Ascherio A; Parkinson Study Group SURE-PD Investigators. Schwarzschild MA, et al. Lancet Neurol. 2014 Aug;13(8):758. doi: 10.1016/S1474-4422(14)70138-3. Lancet Neurol. 2014. PMID: 25030508 No abstract available.